EUVIMEDEUVIMED entdecken
Crossref

Multi-parametric 18F-Flurpiridaz-PET/CT using a long axial field-of-view PET/CT in advanced chronic coronary syndrome

J Diekmann, T König, L R Nikoukar, S Ziegler, J Bauersachs, F Bengel

Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 144

DOI: 10.1055/s-0046-1818288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von J Diekmann und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziel/Aim: To evaluate the feasibility of list-mode 18 F-flurpiridaz PET/CT for comprehensive assessment of the functional aspects of chronic coronary syndrome using a long axial field-of-view (LAFOV) PET/CT system. Methodik/Methods: 7 patients with known advanced multi-vessel coronary disease underwent list-mode 18 F-flurpiridaz imaging for assessment prior to planned revascularization (total of 11 scans; 15 min acquisition started directly after bolus injection; 7 rest, 4 regadenoson stress; rest dose 105±10 MBq; stress dose 229±56 MBq, 30 min after rest) on a 148cm-LAFOV PET/CT (Panorama GS, UIH). A cardiac field-of-view (50 cm) was extracted from total-body datasets for reconstruction of static, gated and dynamic series and further analysed using 4DM software (Invia). Additionally, total body dynamic images were created and tested for parametric analysis (single tissue model including bolus delay correction) of multiple organs (ukinetics software, UIH). Ergebnisse/Results: Mean SSS was 16±2, mean SRS 12±4. Mean stress left ventricular ejection fraction (LVEF) was 42±1%, mean rest LVEF 46±12%. Global stress myocardial blood flow (MBF) was significantly higher than rest MBF (1.8±0.4 vs. 0.7±0.1 ml/min/g; p=0.006). Flow reserve (MFR) ranged from 1.4 to 3.5 and was relatively high despite advanced disease. Correction of stress cardiac data for residual activity was feasible and required to avoid artifactual elevation of stress MBF and MFR (2.5±0.2 ml/min/g and 3.6±0.8 without corr). Global stress MBF correlated with SSS (r=0.953; p=0.047), while rest MBF did not correlate with SRS. Total body datasets yielded parametric K1 images at rest, where MBF from parametric imaging was in the range of results from extracted cardiac datasets, while K1-values for e.g. brain and kidney were obtained, but require further validation. Stress total-body images were not readily analyzed due to lack of residual correction. Schlussfolgerungen/Conclusion: Dynamic 18 F-flurpiridaz PET/CT using a long axial field-of-view system enables robust and comprehensive assessment of patients with advanced chronic coronary syndrome using validated cardiac imaging software. Additional functional parameters going beyond those standard measures may be explored as clinical application is expanded. Publication History Article published online: 02 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Diekmann, J., König, T., Nikoukar, L. R., Ziegler, S., Bauersachs, J., & Bengel, F. (2026). Multi-parametric 18F-Flurpiridaz-PET/CT using a long axial field-of-view PET/CT in advanced chronic coronary syndrome. Nuklearmedizin - NuclearMedicine, 65(02), 144. https://doi.org/10.1055/s-0046-1818288

Vancouver

Diekmann J, König T, Nikoukar LR, Ziegler S, Bauersachs J, Bengel F. Multi-parametric 18F-Flurpiridaz-PET/CT using a long axial field-of-view PET/CT in advanced chronic coronary syndrome. Nuklearmedizin - NuclearMedicine. 2026;65(02):144. doi:10.1055/s-0046-1818288

BibTeX
@article{Diekmann2026,
  author = {Diekmann, J and König, T and Nikoukar, L R and Ziegler, S and Bauersachs, J and Bengel, F},
  title = {Multi-parametric 18F-Flurpiridaz-PET/CT using a long axial field-of-view PET/CT in advanced chronic coronary syndrome},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {02},
  pages = {144},
  doi = {10.1055/s-0046-1818288}
}
Kostenlos starten →